William T. Jorgensen

The Nonpeptide Oxytocin Receptor Agonist WAY 267,464: Receptor‐Binding Profile, Prosocial Effects and Distribution of c‐Fos Expression in Adolescent Rats

Callum Hicks, William T. Jorgensen, Christopher Brown et al. · Journal of Neuroendocrinology · 2012 · 77 citations · Full text

Neuroendocrinology, C‐fos Expression, Pharmacotherapy +21

Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands

Samuel D. Banister, Iman A. Moussa, Corinne Beinat et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 19 citations · Full text

Functional Selectivity, Selective Dopamine Transporter, Medicine +8

The Formation of Seven-Membered Heterocycles under Mild Pictet–Spengler Conditions: A Route to Pyrazolo[3,4]benzodiazepines

Timothy A. Katte, Tristan A. Reekie, William T. Jorgensen et al. · The Journal of Organic Chemistry · 2016 · 19 citations

Molecular hybridization of 4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity

Samuel D. Banister, Iman A. Moussa, William T. Jorgensen et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 14 citations · Full text

Molecular Pharmacology, Diversity Oriented Synthesis, Drug Target +11

Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1 a receptors

William T. Jorgensen, Damien W. Gulliver, Eryn L. Werry et al. · European Journal of Medicinal Chemistry · 2015 · 12 citations · Full text

Molecular Pharmacology, Functional Selectivity, Medicine +9